Jpmorgan Chase & CO Science 37 Holdings, Inc. Transaction History

Jpmorgan Chase & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.21 - $0.59 $15 - $44	76 Added 55.07%	214 $0
Q2 2023 Aug 11, 2023	SELL	$0.21 - $0.39 $10,117 - $18,789	-48,177 Reduced 99.71%	138 $0
Q1 2023 May 18, 2023	BUY	$0.22 - $0.62 $10,598 - $29,869	48,177 Added 34910.87%	48,315 $13,000
Q1 2023 May 11, 2023	SELL	$0.22 - $0.62 $7,753 - $21,850	-35,242 Reduced 99.61%	138 $0
Q4 2022 Feb 13, 2023	BUY	$0.38 - $1.91 $691 - $3,478	1,821 Added 5.43%	35,380 $15,000
Q3 2022 Nov 14, 2022	BUY	$1.46 - $2.38 $397 - $647	272 Added 0.82%	33,559 $54,000
Q2 2022 Aug 11, 2022	BUY	$1.98 - $5.66 $37,051 - $105,915	18,713 Added 128.4%	33,287 $67,000
Q1 2022 May 11, 2022	BUY	$4.52 - $12.9 $14,789 - $42,208	3,272 Added 28.95%	14,574 $78,000
Q4 2021 Feb 10, 2022	BUY	$9.01 - $14.1 $101,831 - $159,358	11,302 New	11,302 $141,000

43.3K

Ticker SNCE
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 116,348,000
Description
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.